Roivant Sciences Ltd. ROIV | NASDAQ

$11.09 -$0.19 | -1.64%

Next Earnings: Aug 06, 2025

Company Overview:

Market Cap: $7.54B
PE Ratio: -14.78
52-Week Range: $8.73 - $13.06

4.6 Year ROIV Performance Metrics:

Total Return (with DRIP): 7.2% (1.53% CAGR)
Total Return (no DRIP): 7.2% (1.53% CAGR)
Share Price: 7.2% (1.53% CAGR)
ROIV Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ROIV Earnings, Revenue, Cash & Debt, Shares Outstaning:

ROIV - Revenue
7-Day FREE Trial Get Full Access Now!
ROIV Revenue CAGR:1Y: -73.83%2Y: -47.41%5Y: -34.53%10Y: 0.00%
ROIV - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
ROIV EPS CAGR:1Y: 54.09%2Y: 9.92%5Y: 3.01%10Y: 0.00%
ROIV - Net Income
7-Day FREE Trial Get Full Access Now!
ROIV Net Income CAGR:1Y: 36.63%2Y: 8.49%5Y: 28.03%10Y: 0.00%
ROIV - EBITDA
7-Day FREE Trial Get Full Access Now!
ROIV EBITDA CAGR:1Y: -105.55%2Y: 18.15%5Y: N/A10Y: 0.00%
ROIV - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
ROIV Free Cash Flow CAGR:1Y: 59.34%2Y: -2.05%5Y: 0.00%10Y: 0.00%
ROIV - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
ROIV Free Cash Flow / Share CAGR:1Y: 80.87%2Y: 0.36%5Y: 0.00%10Y: 0.00%
ROIV - Operating Income
7-Day FREE Trial Get Full Access Now!
ROIV Operating Income CAGR:1Y: 7.13%2Y: 10.31%5Y: 28.13%10Y: 0.00%
ROIV - Gross Profit
7-Day FREE Trial Get Full Access Now!
ROIV Gross Profit CAGR:1Y: -75.60%2Y: -49.22%5Y: 15.21%10Y: 0.00%
ROIV - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
ROIV Shares Outstanding CAGR:1Y: -11.90%2Y: -2.40%5Y: 24.56%10Y: 0.00%
ROIV - Share Buybacks
7-Day FREE Trial Get Full Access Now!
ROIV Share Buybacks CAGR:1Y: 0.00%2Y: 1,332.87%5Y: 0.00%10Y: 0.00%
ROIV - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
ROIV Stock-Based Comp CAGR:1Y: 78.68%2Y: 81.74%5Y: 0.00%10Y: 0.00%
ROIV - Expenses
7-Day FREE Trial Get Full Access Now!
ROIV Expenses CAGR:1Y: 132.38%2Y: -29.29%5Y: 0.00%10Y: 0.00%
ROIV - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
ROIV - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
ROIV - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
ROIV - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
ROIV - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
ROIV - Cash & Debt
7-Day FREE Trial Get Full Access Now!
ROIV - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
ROIV Revenue CAGR:1Y: -73.83%2Y: -47.41%5Y: -34.53%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ROIV - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ROIV Actual Revenue CAGR:1Y: -73.83%2Y: -47.41%5Y: -34.53%10Y: 0.00%
ROIV - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ROIV Actual EPS CAGR:1Y: 54.09%2Y: 9.92%5Y: 3.01%10Y: 0.00%
ROIV - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ROIV Actual Net Income CAGR:1Y: 36.63%2Y: 8.49%5Y: 28.03%10Y: 0.00%
ROIV - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ROIV Actual EBITDA CAGR:1Y: -105.55%2Y: 18.15%5Y: N/A10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ROIV - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
ROIV Net Profit Margin CAGR:1Y: 422.17%2Y: 106.31%5Y: 0.00%10Y: 0.00%
ROIV - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
ROIV Gross Profit Margin CAGR:1Y: -6.76%2Y: -3.44%5Y: 0.00%10Y: 0.00%
ROIV - Price to Earnings
7-Day FREE Trial Get Full Access Now!
ROIV - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
ROIV - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
ROIV - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ROIV

Based on past 4.6-year performance, here are ROIV growth metrics:

Share price CAGR of +1.53%
Dividend CAGR of +0%

Using ROIV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ROIV (DRIP)ROIV - No DRIP
Current Price$11.15$11.15
Start Shares896.86896.86
Start Value$10,000$10,000
  
After 10 years:
Final Share Count896.86896.86
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$12.78$11.15
Total Dividends$0$0
Final Value$11,460$10,000

Estimated Future Value + Dividends - ROIV

NOTE: Above numbers are our estimate based on ROIV's Dividend and Price CAGR over past 4.6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Roivant Sciences Ltd. (ROIV) had its IPO on 2020-12-08, and is trader on NASDAQ stock exchange.

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

ROIV website: https://roivant.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial